China, Merger Controls, Merger Reviews

China’s First Court Ruling on Merger Control Upholds Conditional Clearance of Below-Threshold Deal

Dacheng on 5/5/2025

In March 2025, the Beijing Intellectual Property Court issued a landmark ruling—the first case in which a filing party challenged a merger decision by the State Administration for Market Regulation (“SAMR”) through judicial...more

China Unveils New Anti-Monopoly Guidelines for the Pharmaceutical Sector

Jones Day on 2/3/2025

China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The Guidelines provide a comprehensive framework for the State Administration for Market...more

Key Considerations for Managing Multijurisdictional Merger Review Proceedings

TransPerfect Legal on 11/10/2023

During TransPerfect Legal’s third annual Antitrust Clearance and Merger Enforcement conference, a panel of leading antitrust attorneys shared their strategies for overcoming the challenges presented by multijurisdictional...more

New Implementing Regulations of China’s Anti-Monopoly Law: Highlights and Implications

A&O Shearman on 4/20/2023

Following last year’s significant amendments to the PRC Anti-Monopoly Law (2022 AML) the State Administration for Market Regulation (SAMR) has published final versions of the accompanying implementing regulations. Taking...more

SAMR delegates merger review powers

Hogan Lovells on 8/30/2022

Yesterday, on 29 August 2022, clearance for the FAW/Refire joint venture transaction was announced on one of the websites of the Chinese antitrust authority – i.e., the State Administration for Market Regulation. That...more

China Publishes Draft Amendments to Anti-Monopoly Law

Skadden, Arps, Slate, Meagher & Flom LLP on 4/28/2020

For the first time since China’s Anti-Monopoly Law (AML) came into force in 2008, the government is proposing major changes to its centerpiece antitrust legislation. On January 2, 2020, the State Administration for Market...more